Status:
COMPLETED
Using IGF-1 for Nutritional Monitoring
Lead Sponsor:
Wang Xinying
Conditions:
Nutritional Supplement
Eligibility:
All Genders
18+ years
Brief Summary
Nutrition support is critical to a vast number of patients who are hospitalized annually because of critical illnesses or surgery. It is also necessary for patients with chronic intestinal failure (CI...
Detailed Description
Chronic intestinal failure (CIF) is one of the rarest of organ failures all over the world, mainly caused by severe gastrointestinal or systemic benign diseases such as intestinal fistula, short bowel,...
Eligibility Criteria
Inclusion
- All adult CIF patients (age ≥18 years) receiving nutrition support were included
Exclusion
- Hepatic insufficiency (alanine transaminase/aspartate transaminase ratio 200% above normal range or bilirubin \>3 mg/dL), renal insufficiency (serum creatinine \[Scr\] \>1.5 mg/dL), acute or life-threatening diseases (e.g., shock, collapse, stroke, coma of unknown etiology, or recent cardiac infarction), and pregnant or breast-feeding women
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT03277014
Start Date
September 1 2013
End Date
January 1 2017
Last Update
September 8 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.